$42.3
+0.01
(+0.02%)▲
Live
Revenue is up for the last 3 quarters, 354.55M → 369.08M (in $), with an average increase of 2.0% per quarter
Netprofit is up for the last 3 quarters, 2.19M → 45.86M (in $), with an average increase of 69.1% per quarter
0.0%
Downside
Day's Volatility :0.54%
Upside
0.54%
27.92%
Downside
52 Weeks Volatility :31.33%
Upside
4.73%
Period | Adtalem Global Education Inc. | Sector (Consumer Discretionary) | Index (Russel 2000) |
---|---|---|---|
3 Months | 8.1% | 4.4% | -6.7% |
6 Months | 1.66% | 4.0% | -6.2% |
1 Year | 29.64% | -1.2% | -6.3% |
3 Years | 24.27% | 22.4% | 26.9% |
Market Capitalization | 1.8B |
Book Value | $34.15 |
Dividend Share | 0.0 |
Dividend Yield | 0.0% |
Earnings Per Share (EPS) | 1.82 |
PE Ratio | 23.24 |
PEG Ratio | 0.59 |
Wall Street Target Price | 45.33 |
Profit Margin | 5.82% |
Operating Margin TTM | 16.01% |
Return On Assets TTM | 4.55% |
Return On Equity TTM | 5.69% |
Revenue TTM | 1.5B |
Revenue Per Share TTM | 32.09 |
Quarterly Revenue Growth YOY | 1.3% |
Gross Profit TTM | 727.3M |
EBITDA | 347.4M |
Diluted Eps TTM | 1.82 |
Quarterly Earnings Growth YOY | -0.86 |
EPS Estimate Current Year | 4.16 |
EPS Estimate Next Year | 4.48 |
EPS Estimate Current Quarter | 0.91 |
EPS Estimate Next Quarter | 1.11 |
What analysts predicted
Upside of 7.16%
FY17 | Y/Y Change | |
---|---|---|
Revenue | 1.8B | ↓ 1.83% |
Net Income | 122.3M | ↓ 3962.38% |
Net Profit Margin | 6.76% | ↑ 6.93% |
FY18 | Y/Y Change | |
---|---|---|
Revenue | 1.2B | ↓ 31.97% |
Net Income | 33.8M | ↓ 72.38% |
Net Profit Margin | 2.74% | ↓ 4.02% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 1.2B | ↑ 0.69% |
Net Income | 95.2M | ↑ 181.82% |
Net Profit Margin | 7.68% | ↑ 4.94% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 1.1B | ↓ 15.14% |
Net Income | -85.3M | ↓ 189.67% |
Net Profit Margin | -8.11% | ↓ 15.79% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 1.1B | ↑ 5.74% |
Net Income | 76.9M | ↓ 190.13% |
Net Profit Margin | 6.91% | ↑ 15.02% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 1.4B | ↑ 24.7% |
Net Income | 317.7M | ↑ 313.09% |
Net Profit Margin | 22.9% | ↑ 15.99% |
Q4 FY21 | Q/Q Change | |
---|---|---|
Revenue | 371.2M | ↑ 6.57% |
Net Income | 17.9M | ↓ 130.78% |
Net Profit Margin | 4.81% | ↑ 21.46% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Revenue | 365.6M | ↓ 1.5% |
Net Income | 349.8M | ↑ 1859.57% |
Net Profit Margin | 95.68% | ↑ 90.87% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Revenue | 361.2M | ↓ 1.2% |
Net Income | 8.0M | ↓ 97.71% |
Net Profit Margin | 2.22% | ↓ 93.46% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 354.6M | ↓ 1.85% |
Net Income | 2.2M | ↓ 72.65% |
Net Profit Margin | 0.62% | ↓ 1.6% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 363.3M | ↑ 2.47% |
Net Income | 24.1M | ↑ 1001.46% |
Net Profit Margin | 6.65% | ↑ 6.03% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 369.1M | ↑ 1.59% |
Net Income | 45.9M | ↑ 89.98% |
Net Profit Margin | 12.43% | ↑ 5.78% |
FY17 | Y/Y Change | |
---|---|---|
Total Assets | 2.3B | ↑ 10.35% |
Total Liabilities | 645.0M | ↑ 25.26% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 2.3B | ↑ 1.34% |
Total Liabilities | 825.7M | ↑ 28.01% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 2.2B | ↓ 4.36% |
Total Liabilities | 851.2M | ↑ 3.09% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 2.2B | ↓ 0.62% |
Total Liabilities | 918.3M | ↑ 7.88% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 3.1B | ↑ 37.02% |
Total Liabilities | 1.8B | ↑ 90.88% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 3.0B | ↓ 0.81% |
Total Liabilities | 1.5B | ↓ 13.05% |
Q4 FY21 | Q/Q Change | |
---|---|---|
Total Assets | 3.7B | ↓ 2.88% |
Total Liabilities | 2.4B | ↓ 5.31% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 3.5B | ↓ 3.86% |
Total Liabilities | 2.0B | ↓ 14.47% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 3.0B | ↓ 13.91% |
Total Liabilities | 1.5B | ↓ 24.82% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 3.0B | ↓ 1.09% |
Total Liabilities | 1.5B | ↓ 2.5% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 2.8B | ↓ 5.11% |
Total Liabilities | 1.3B | ↓ 11.15% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 2.9B | ↑ 0.85% |
Total Liabilities | 1.4B | ↑ 2.76% |
FY17 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 228.0M | ↓ 1.56% |
Investing Cash Flow | -379.7M | ↑ 76.25% |
Financing Cash Flow | 88.8M | ↓ 235.32% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 239.2M | ↑ 4.92% |
Investing Cash Flow | -71.5M | ↓ 81.18% |
Financing Cash Flow | 37.2M | ↓ 58.1% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 204.9M | ↓ 14.35% |
Investing Cash Flow | -213.8M | ↑ 199.28% |
Financing Cash Flow | -137.5M | ↓ 469.67% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 107.7M | ↓ 47.43% |
Investing Cash Flow | 382.5M | ↓ 278.89% |
Financing Cash Flow | -256.1M | ↑ 86.22% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 192.2M | ↑ 78.47% |
Investing Cash Flow | -56.7M | ↓ 114.82% |
Financing Cash Flow | 676.5M | ↓ 364.13% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 10.4M | ↓ 94.58% |
Investing Cash Flow | -551.6M | ↑ 873.09% |
Financing Cash Flow | -424.5M | ↓ 162.75% |
Q4 FY21 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -19.0M | ↓ 146.42% |
Investing Cash Flow | -15.9M | ↓ 98.93% |
Financing Cash Flow | 515.4M | ↑ 0.07% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 50.4M | ↓ 365.65% |
Investing Cash Flow | 964.1M | ↓ 6158.87% |
Financing Cash Flow | -548.3M | ↓ 206.38% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -41.1M | ↓ 181.48% |
Investing Cash Flow | -10.7M | ↓ 101.11% |
Financing Cash Flow | -391.6M | ↓ 28.58% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 91.4M | ↓ 322.6% |
Investing Cash Flow | -6.4M | ↓ 40.48% |
Financing Cash Flow | -103.0M | ↓ 73.7% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -50.0M | ↓ 154.69% |
Investing Cash Flow | -6.6M | ↑ 3.1% |
Financing Cash Flow | -63.4M | ↓ 38.39% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 108.0M | ↓ 316.09% |
Investing Cash Flow | 43.6M | ↓ 765.01% |
Financing Cash Flow | -44.5M | ↓ 29.93% |
Sell
Neutral
Buy
Adtalem Global Education Inc. is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Adtalem Global Education Inc. | 3.6% | 1.66% | 29.64% | 24.27% | -10.97% |
![]() Grand Canyon Education Inc | -11.58% | -6.16% | 19.0% | 7.41% | -3.79% |
![]() Graham Holdings | -1.83% | -11.51% | -7.08% | 58.84% | -3.28% |
![]() Strategic Education Inc | -11.86% | -2.95% | 20.62% | -53.99% | -27.29% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Adtalem Global Education Inc. | 23.24 | 23.24 | 0.59 | 4.16 | 0.06 | 0.05 | 0.0 | 34.15 |
![]() Grand Canyon Education Inc | 18.11 | 18.11 | 0.93 | 6.47 | 0.27 | 0.16 | 0.0 | 21.72 |
![]() Graham Holdings | 108.7 | 108.7 | 0.0 | 42.0 | 0.01 | 0.03 | 0.01 | 786.63 |
![]() Strategic Education Inc | 50.89 | 50.89 | 1.6 | 3.0 | 0.02 | 0.02 | 0.03 | 66.15 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Adtalem Global Education Inc. | Buy | $1.8B | -10.97% | 23.24 | 5.82% |
![]() Grand Canyon Education Inc | Buy | $3.3B | -3.79% | 18.11 | 20.29% |
![]() Graham Holdings | Sell | $2.7B | -3.28% | 108.7 | 0.59% |
![]() Strategic Education Inc | Buy | $2.0B | -27.29% | 50.89 | 3.54% |
BlackRock Inc
Vanguard Group Inc
FMR Inc
Ariel Investments, LLC
Dimensional Fund Advisors, Inc.
State Street Corporation
In the quarter ending June,2016. Adtalem Global Education Inc. has declared dividend of $0.18
Read MoreAdtalem Global Education Inc. is a leading global education provider and the parent organization of American University of the Caribbean School of Medicine, Association of Certified Anti-Money Laundering Specialists, Becker Professional Education, Chamberlain University, EduPristine, Ross University School of Medicine and Ross University School of Veterinary Medicine.
Organization | Adtalem Global Education Inc. |
Employees | 4682 |
CEO | Mr. Stephen W. Beard |
Industry | Consumer Services |
USANA Health Sciences Inc.
$62.03
-1.18%
Herbalife Ltd.
$11.75
-1.34%
51Talk Online Education Group
$5.69
-9.39%
Fresh Del Monte Produce Inc.
$26.11
-1.62%
BRF S.A.
$1.52
-2.56%
Hain Celestial Group, Inc., The
$12.75
-1.39%
Nu Skin Enterprises Inc.
$34.15
-1.16%
Natural Health Trends Corp.
$5.51
-0.18%
Big Lots Inc.
$6.09
-2.56%